Determinants of the outcomes of patients with cancer infected with SARS-CoV-2: results from the Gustave Roussy cohort

Laurence Albigès(Institut Gustave Roussy), Fabrice Barlési(Institut Gustave Roussy), Jean‐Baptiste Micol(Université Paris-Saclay), Dominique Valteau‐Couanet(Université Paris-Saclay), Annabelle Stoclin(Institut Gustave Roussy), Jean‐Charles Soria(Commissariat à l'Énergie Atomique et aux Énergies Alternatives), Mathilde Hauchecorne(Université Paris-Saclay), Stéphanie Foulon(Université Paris-Saclay), Benjamin Besse(Université Paris-Sud), Christophe Willekens(Université Paris-Saclay), Samy Ammari(Université Paris-Saclay), Nathalie Chaput(Inserm), Thomas Hueso(Université Paris-Sud), Florence Netzer(Université Paris-Saclay), Véronique Saada(Université Paris-Saclay), Corinne Balleyguier(Université Paris-Saclay), Émeline Colomba(Université Paris-Saclay), Audrey Perret(Université Paris-Saclay), Arnaud Bayle(Université Paris-Saclay), Julien Hadoux(Université Paris-Saclay), Florian Scotté(University of Derby), Fanny Pommeret(Université Paris-Saclay), Jean‐Marie Michot(Université Paris-Saclay), Antoine Hollebecque(Institut Gustave Roussy), Bertrand Gachot(Université Paris-Saclay), Mansouria Merad(Université Paris-Saclay), Roger Sun(Inserm), Frank Griscelli(Université Paris-Saclay), Fabrice André(Inserm), Giulia Baciarello(Université Paris-Saclay), Ludovic Lacroix(Institut Gustave Roussy)

Nature Cancer

September 22, 2020

Cited by 119

Related Papers

|Science|2017|5.4k

|The Lancet|2016|4.8k

|New England Journal of Medicine|2013|3.4k

|Annals of Oncology|2016|2.1k

|Cancer Discovery|2017|2k